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ABSTRACT 
The incidence of cancer especially breast cancer is increasing alarmingly worldwide with a high 
percentage of death especially in developing countries. The Ayurvedic system treasures a host of 
medicinal formulations that have been shown to possess cytotoxic effects on tumor cell lines. 
Recently herbal medicines are coming to play a more vital role in the reduction and prevention of 
cancer. Boerhaavia diffusa L. (Punarnava), an annual herb has been used for managing wide range 
of diseases including cancer. This herb was also screened for various pharmacological activities 
like anti-inflammatory, anti-oxidant, immunomodulatory, anti-angiogenic, anti-metastatic 
activities and others. The decoction of root of Boerhaavia diffusa L. (Punarnava) was not 
scientifically evaluated for cytotoxicity. So the current study investigates the In vitro Cytotoxicity 
of root of decoction of Punarnava (Boerhaavia diffusa L.) in breast cell line (MCF-7). The five 
different concentrations of decoction of Punarnava (Boerhaavia diffusa Linn.) were used for 
Invitro Cytotoxicity by MTT assay at 24 hours and 48 hours. The test sample exhibits cytotoxicity 
of about 65.1±1.2at 800 µg/ ml concentration (48 hours) of incubation in MCF-7 breast cell line. 
The results were also analyzed statistically. It showed that there is highly significant difference in 
the percentage of inhibition of test sample in concentration from 50µg/ml -800µg/ml. The findings 
of this investigation concluded that the study drug Boerhaavia diffusa L. (Punarnava) has anti-
cancer activity in MCF-7 breast cell line. 
KEYWORDS: Punarnava, Boerhaavia diffusa L., Cytotoxicity, Breast cancer, Breast cell line, MTT 
assay, Arbudam. 
INTRODUCTION
Cancer is one of the most dreadful diseases. 
Many efforts have been taken to find a complete cure 
but yet success is still far. Recent study showed that 
7lakh people die of cancer every year in India. In 
2012, WHO released new statistics on cancer 
incidence, mortality and prevalence worldwide 
(GLOBACAN 2012) estimates 28types of cancer in 
184 countries in which there is more prevalence of 
breast cancer. [1] 
On analyzing the description of neoplasm as 
Granthi, Arbudam etc in Ayurvedic classics, it can be 
assumed that Arbudam can be correlated as a 
malignant neoplasm[2]. Surgery, chemotherapy and 
radiotherapy are considered as the most common 
methods of cancer treatment. Although these 
methods are highly effective methods of cancer 
treatment, they exert severe side effects in use. One 
of the main problems in cancer treatment is gradual 
resistance of cancer cells against treatment. 
Therefore modern medical research focuses on 
finding new anticancer agents in order to reduce the 
existing resistance mechanisms. Herbs and other 
natural plant products have become the main source 
for this purpose. Herbal medicines play a vital role in 
the prevention and treatment of cancer. Herbal drugs 
include plants, herbal complexes or even a 
combination of plants, which were used thousand 
years before inventing modern drugs. The Ayurvedic 
system treasures a host of medicinal formulations 
that have been shown to possess cytotoxic effects on 
tumor cell lines. Several medicinal plants have been 
screened based on the integrative approaches on 
drug development from Ayurveda. 
Boerhaavia diffusa L. from the family 
Nyctaginaceae, is a variable diffusely branched low 
spreading or creeping herbaceous perennial 
hogweed, commonly occurring abundantly in waste 
places, ditches and marshy places during rains[3] 
(Fig.1). It is a commonly used medicinal herb in 
Ayurveda. Root is mainly used in the medicinal 
preparations while the leaf is used as a food. 
Etymologically the term Punarnava (punar -again and 
Int. J. Ayur. Pharma Research, 2018;6(6):1-5 
     Available online at: http://ijapr.in  2 
nava -fresh) that which becomes fresh again, that is it 
sprouts up or receives again every year [4]. The 
Ayurveda textbooks, which have evolved from the 
practical knowledge of the Vaidyas of Kerala 
prominently, mention widespread utility of this drug.  
Qualitative analysis of root of Punarnava (Boerhaavia 
diffusa Linn) revealed that it contains an alkaloid 
Punarnavine which exhibits anti-inflammatory, anti-
oxidant, immunomodulatory, anti-angiogenic, anti-
metastatic activities. It induces apoptosis in B16F-10 
melanoma cells. Roots are rich in rotenoids which is 
having anti-cancer activity is also proven. 
Boeravinone, which is also present in Punarnava, also 
shows anti-oxidant and anti-cancer activity. Ursolic 
acid is also proven that it inhibits various cancer cell 
types such as fibrosarcoma. It also induces apoptosis 
in certain cancer cells are also proven. In a test on 
oestrogen-responsive breast cancer cells (MCF-7) at 
doses of 20-320 mcg/ml, methanol extract of root of 
Boerhaavia diffusa reduced viability of cancer cells by 
46.8%. Two rotenoids, boeravinones G and H isolated 
from roots were found to inhibit breast cancer 
resistance protein ABCG2 [5-10]. These findings suggest 
that the herb have the potential for the treatment of 
breast cancer. Hence the present study aimed to 
screen the cytotoxicity of concentrated decoction of 
Boerhaavia diffusa L. in breast cancer cell line (MCF 
7). 
MATERIALS AND METHODS 
Materials 
The plant material used in this research was 
mature root of Punarnava (Boerhaavia diffusa L.), 
collected from natural habitat and was shade dried 
and stored in airtight containers. (Fig.2) (Fig.3) 
MCF-7 (Human Breast Cancer cells) was obtained 
from National Centre for Cell Sciences, Pune, India. 
Methodology of preparation of drug 
Step 1 (Preparation of decoction) 
48gm of coarsely powdered root of 
Punarnava was mixed with 16 times of water and 
reduced to 96ml (1/8th) and strained through clean 
white cloth according to Kwatha preparation 
procedure mentioned in Sarngadhara samhitha.[11] 
Step 2 (Filtration of decoction) 
Using Whatman’s filter paper of pore size 1 
again decoction was filtered. 
Step 3 (Concentration of Decoction) 
Punarnava decoction was collected after the 
filtration. It was then transferred to borosil glass 
beaker and kept over a hot water bath and heated. 
Heating was continued till almost all water gets 
evaporated from the decoction. It was then stored in 
petridish and sealed it carefully and stored in 
refrigerator. Of them 0.002gm of concentrated 
decoction of Punarnava (Boerhaavia diffusa Linn) 
was dissolved in 1ml triple distilled water and was 
taken up for the study. (Fig.4) (Fig.5) 
 Tissue culture 
a. Sterilisation of glassware 
All glassware and filtration apparatus used 
for tissue culture were soaked in solution of 5% 
Savlon overnight, cleaned using brush and washed 
thoroughly under running water. They were then 
soaked in boiling water for 15 minutes and rinsed in 
distilled water and dried in a hot air oven. These 
were then autoclaved at a pressure of about 15lbs for 
15 minutes, dried and used for experiments. 
b. Preparation of culture media 
DMEM (Dulbecos Modified Eagle’s medium) 
was prepared by mixing DMEM powder of about 
1.03gm in autoclaved triple distilled water. To this 
1.95gm of Hepes buffer, 3.75gm sodium bicarbonate 
and antibiotics like Penicillin (100μg/ml), 
Streptomycin (100μg/ml), Amphotericin-B(100μg/ 
ml) were added. This was the amount of drugs should 
be added in 1000ml of triple distilled water. The pH 
was confirmed to be 7.2-7.4 using pH meter and 
adjustments made if needed. It was filtered under 
negative pressure using 0.22μm cellulose filter. 10% 
FBS (Foetalbovein serum) was mixed with the 
medium before used for culture. 
c. Maintenance of adherent breast cell lines 
Adherent cells MCF-7(Michigan Cancer 
Foundation-7) was cultured in tissue culture flasks. 
The cells were disaggregated by Trypsinization and 
sub cultured when the monolayer reached about 
70% confluency. Cells were also cryopreserved at -
80◦ C. With an inverted microscope, degree of 
confluency of the cell monolayer was assessed and 
the absence of bacterial and fungal contaminants was 
confirmed. Spent medium was removed. Cells were 
washed with PBS-EDTA (Phosphate buffered saline-
Ethylene diamine tetra acetic acid) for removing all 
the traces of serum. Trypsin was applied on to the 
cell monolayer, and the flask was swirled to cover the 
monolayer with Trypsin. Flask was incubated at 37◦ C 
for 2-3 minutes. The Flask was examined under the 
inverted microscope to ensure uniform detachment 
of the cells. 1-2 ml of medium was added to the flask 
as fast as possible to reduce the Trypsin induced 
stress, and the contents of the flask transferred to a 
centrifuge tube. Cells were then centrifuged at 1500 
rpm to 2000 rpm, for 10 minutes. The supernatant 
was discarded, and the cells were re-suspended in 
minimum volume of medium. Cells were counted 
using a Haemocytometer and used for subculture, 
storage and experimental purposes. 
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Invitro Cytotoxicity on MCF-7 cells by MTT 
method 
The cells were harvested, counted and seeded 
(5000 cells/well) in 96 well plates and PBS was 
added to the outer wells. DMEM is added to all the 
wells mixed with 10% FBS. After 24 hours of 
incubation at 37°C in 5% CO2 incubator to allow cell 
attachment. Then the media were removed. Cultures 
were treated with test sample Boerhaavia diffusa L. in 
different concentrations such as 50µg/ml, 100µg/ml, 
200µg/ml, 400µg/ml, 800µg/ml. Again medium was 
added along with 10% FBS. Untreated cancer cells 
served as negative control. The plates were then 
incubated at two stages for 24 and 48hours. On 
completion of each stage of incubation, media were 
removed without disturbing the cells and to each 
well, 100µl of 1mg/ml solution of MTT were added. 
Plates were then incubated for 2hours in dark at 
37ºC. 100µl of lysis buffer was added to each well 
and the plates were further incubated for 4hours in 
dark in a 37ºC incubator and absorbance was read 
using ELISA multi plate reader at 570nm. Triplicates 
were set up for each concentration. (Fig.6) The 
percentage of growth inhibition was calculated as 
follows.[12] 
100- Absorbance of the Drug treated cells  ×100 
Absorbance of untreated control cells 
RESULTS  
The result of Invitro Cytotoxicity assay by 
MTT method for Boerhaavia diffusa L. at 24 and 48 
hours in MCF-7 cell line were as follows 
OD value for test control - 1.425 
During 24 hours, the test sample Boerhaavia 
diffusa L. shows cytotoxicity of about 14.2%, 20.3%, 
21.4%, 27% and 31.2% in 50,100,200,400 and 800 
µg/ml concentrations receptively where as in 48 
hours it shows 31.2%, 36%, 42.3%, 56.5% and 65.1% 
in 50,100,200,400 and 800µg/ml concentrations 
receptively. (fig.7)  
IC 50 values was also obtained from sigma plot 
software for the test sample Boerhaavia diffusa L. and 
is about 295 µg/ml 
The mean percentage of inhibition of test 
samples Boerhaaviadiffusa L. was statistically 
evaluated. The results obtained are 
Table 1: Invitro Cytotoxicity of Boerhaavia diffusa L. in MCF-7 cell line 
Test drug 
 
Concentration  
µ g/ ml  
  48 hour  
Mean SD p value Mean SD p value 
BD 50 14.2 1.5 <0.001 31.2 0.6 <0.001 
100 20.3 0.7 36 0.8 
200 21.4 1.5 42.3 1.5 
400 27.0 0.6 56.5 2.5 
800 31.2 0.5 65.1 1.2 
* Boerhaavia diffusa L. 
DISCUSSION 
Cancer can be defined as a disease in which a 
group of abnormal cells grow uncontrollably by 
disregarding the normal rules of cell division. Breast 
cancer is characterized by the uncontrolled growth of 
abnormal cells in the milk producing glands of the 
breast or in the passages that deliver milk to the 
nipples. Each year 1- 1.5 million new cases of breast 
cancer are being added all over the world. For the 
treatment of cancer modern science has developed 
many drugs but this drug burdened the patient by 
their cost and drug induced toxic effects. Also there is 
a common belief that anticancer drugs produce non-
selective cell killing of normal as well as cancerous 
tissues. So in the present era poly herbal 
formulation/single herbal drugs have got more 
importance. Many scientific researchers have drawn 
attention to anticancer properties of medicinal herbs. 
The present study is taken up an attempt to evaluate 
the cytotoxic effect of decoction of herbal drug 
Punarnava (Boerhaavia diffusa L.) in MCF-7 breast 
cell line. The test sample Boerhaavia diffusa showed 
maximum cytotoxicity of about 65.1% at 48 hours in 
800µg/ml concentration and there is a trend showing 
that when the concentration and time period 
increases the percentage of inhibition also increases. 
Statistically also its significance was calculated and it 
indicted that the values are highly significant from 
concentrations 50 µg/ ml - 800 µg/ ml.  
CONCLUSION 
The results of present study demonstrated 
that the herbal drug Punarnava (Boerhaavia diffusa 
L) has got cytotoxicity in MCF-7 cell line. This may be 
due to the phytoconstituents present in the root of 
the drug or due to its Dravyaprabhavam (specific 
action of drug). Thus the study drug has the potential 
to become a good anticancer agent. However, in vivo 
studies have to be carried out to substantiate the in 
vitro results by employing different in vivo models 
and clinical trials for their effective utilization as 
therapeutic agents.  
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Fig.1 Boerhaavia diffusa L Fig.2 Root of Boerhaavia diffusa L. 
 
Fig. 3 Dried root of Boerhaavia diffusa L. Fig. 4 Concentrated decoction of Boerhaavia diffusa L. 
 
Fig.5 Concentrated 
decoction of Boerhaavia 
diffusa diluted with 1ml 
triple distilled water 
Fig.6 MTT assay plate added with 
test sample 
 
Fig. 7 Graph showing the mean percentage 
of inhibition of Boerhaavia diffusa at 24 and 
48 hours 
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